Cargando…

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37

Peri-implantitis is a pathological condition involving tissues around dental implants that are characterized by inflammation of the peri-implant mucosa and progressive loss of supporting bone. We found that the antimicrobial peptide KR-12-3 (KRIVKWIKKFLR) derived from LL-37 had antibacterial propert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Haiwei, Zhang, Xi, Li, Maogen, Zhang, Qian, Wang, Yonglan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220503/ https://www.ncbi.nlm.nih.gov/pubmed/35740160 http://dx.doi.org/10.3390/antibiotics11060754

Ejemplares similares

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
por: Lu, Fatai, et al.
Publicado: (2022)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability
por: Gunasekera, Sunithi, et al.
Publicado: (2020)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
por: Findlay, Emily Gwyer, et al.
Publicado: (2019)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
por: Davidopoulou, Sotiria, et al.
Publicado: (2014)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37
por: Choi, Heejun, et al.
Publicado: (2017)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
por: Pahar, Bapi, et al.
Publicado: (2020)

Lipidated Analogs of the LL-37-Derived Peptide Fragment KR12—Structural Analysis, Surface-Active Properties and Antimicrobial Activity
por: Kamysz, Elżbieta, et al.
Publicado: (2020)

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis
por: Hitchon, Carol A, et al.
Publicado: (2019)

Antibacterial and Anti-Inflammatory Properties of Peptide KN-17
por: Zhang, Qian, et al.
Publicado: (2022)

Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties
por: Al-Adwani, Salma, et al.
Publicado: (2020)

Expressions of Antimicrobial Peptides LL-37, Human Beta Defensin-2 and -3 in the Lesions of Cutaneous Tuberculosis and Tuberculids
por: Zhao, Zheng, et al.
Publicado: (2016)

Antibacterial Properties of Small-Size Peptide Derived from Penetratin against Oral Streptococci
por: Li, Meng, et al.
Publicado: (2021)

Anti-adenoviral Effects of Human Cationic Antimicrobial Protein-18/LL-37, an Antimicrobial Peptide, by Quantitative Polymerase Chain Reaction
por: Uchio, Eiichi, et al.
Publicado: (2013)

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice
por: Lee, In Hye, et al.
Publicado: (2017)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2022)

Novel Hybrid Peptide Cecropin A (1–8)-LL37 (17–30) with Potential Antibacterial Activity
por: Wei, Xu-Biao, et al.
Publicado: (2016)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
por: Seil, Michèle, et al.
Publicado: (2010)

Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities
por: Kamysz, Elżbieta, et al.
Publicado: (2023)

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens
por: White, John Kerr, et al.
Publicado: (2022)

Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo
por: Shen, Xinkun, et al.
Publicado: (2019)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
por: Zeth, Kornelius, et al.
Publicado: (2017)

Heterogeneous absorption of antimicrobial peptide LL37 in Escherichia coli cells enhances population survivability
por: Snoussi, Mehdi, et al.
Publicado: (2018)

OmpA-Like Proteins of Porphyromonas gingivalis Mediate Resistance to the Antimicrobial Peptide LL-37
por: Horie, Toshi, et al.
Publicado: (2018)

The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Engelberg, Yizhaq, et al.
Publicado: (2020)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
por: Nagaoka, Isao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7n3cf2g28e544knht86ait8nie